About

Provided by Dechert LLP

Market sources regularly endorse the commercial outlook of Dechert’s Greater China M&A team. We apply a pragmatic, results-based approach that is sensitive to local economic, political and cultural factors, in addition to complying with legal and regulatory requirements. Above all, we know how to get deals done.

Dechert represents buyers, sellers and advisers in sophisticated, complex mergers and acquisitions around the globe. Our deal portfolio includes public and private, negotiated and hostile and multi-million and multi-billion dollar transactions across scores of industries, including financial services, life sciences, healthcare, technology, industrial, consumer, retail, agribusiness, food and beverage, and travel and hospitality.

The M&A practice represents leading private equity firms, public and private companies, global investment advisers and major investment banks. Our imperatives are to structure financeable deals, carry out speed-to-market execution and protect clients’ interests in every transaction phase.

We plan, negotiate and execute the full range of public and private transactions:

  • Acquisitions
  • Divestitures/auctions
  • Joint ventures and collaborations
  • Leveraged buyouts/management buyouts
  • Tender and exchange offers
  • Cross-border transactions
  • Going private-transactions
  • Strategic alliances
  • Proxy contests
  • Special committee assignments
  • Distressed mergers and acquisitions (e.g. bankruptcy)

Chambers Review

Provided by Chambers

Corporate/M&A: Highly Regarded (International Firms) - China

5
Band 5

What the Team is Known For

The notable corporate team at Dechert LLP is able to advise on both inbound and outbound investments involving China. The team is recognised for its handling of M&A deals, privatisations, joint ventures, corporate financings and refinancings. It also acts for an impressive clientele, including clients from the pharmaceutical, financial services and real estate sectors.

Notable practitioners

Wang Yang is a key contact.

Work Highlights

Provided by Dechert LLP

  • Dechert advised Baird Medical Investment on its USD370 million business combination with ExcelFin Acquisition.

Strengths

Provided by Chambers